Impact of Atrial Fibrillation Ablation on Sleep Parameters.
Recruiting
Observational Study
Atrial Fibrillation (AF)
OSA - Obstructive Sleep Apnea
Pulmonary Vein Isolation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Primula Clinics · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Assessment of Sleep Parameters Using Polygraphy in Patients with Paroxysmal Atrial Fibrillation Qualified for Pulmonary Vein Isolation - A Prospective Observational Study: Afib Ablation and Hypopnea Index - The "AAHI" Study
Principal Investigator:
Dr. Paweł Basiukiewicz, MD, PhD
Study Sponsor:
Primula Clinics sp. z o.o. Żyrardowska 31, 05-825 Grodzisk Mazowiecki, Poland NIP (Tax ID): 529 183 0…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria (all must be met):
* Diagnosis of atrial fibrillation (AFib) and scheduled catheter ablation.
* Presence of at least one OSA risk factor: hypertension, male sex, BMI \> 25, diabetes, excessive daytime sleepiness, snoring.
Exclusion Criteria:
\- Absence of predefined sleep apnea…
Contacts